Is there an answer?

IUBMB Life

Volumn 56, Issue 5, 2004, Pages 281-283

  Yu, Bing ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CONNECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; TROPOMYOSIN; TROPONIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ATHLETE; AUTOSOMAL DOMINANT DISORDER; DELETION MUTANT; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MISSENSE MUTATION; NOTE; SUDDEN DEATH; VALVULAR HEART DISEASE; ARTICLE; CHEMISTRY; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; MYOSIN HEAVY CHAINS;

EID: 4644338849     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540412331272254     Document Type: Note

References (8)

1. Maron, B. J. (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287, 1308-1320.
2. McKenna, W. J., Spirito, P., Desnos, M., Dubourg, O. and Komajda, M. (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77, 130-132.
3. Maron, B. J. (2003) Sudden death in young athletes. N. Engl. J. Med. 349, 1064-1075.
4. Geisterfer-Lowrance, A. A., Kass, S., Tanigawa, G., Vosberg, H. P., McKenna, W., Seidman, C. E. and Seidman, J. G. (1990) A molecular basis for familial hypertrophic cardiomyopathy a beta cardiac myosin heavy chain gene missense mutation. Cell 62, 999-1006.
5. Fung, D. C., Yu, B., Littlejohn, T. and Trent, R. J. (1999) An online locus-specific mutation database for familial hypertrophic cardiomyopathy. Hum. Mutat. 14, 326-332.
6. Nanni, L., Pieroni, M., Chimenti, C., Simionati, B., Zimbello, R., Maseri, A., Frustaci, A. and Lanfranchi, G. (2003) Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 309, 391-398.
7. Yu, B., French, J. A., Carrier, L., Jeremy, R. W., McTaggart, D. R., Nicholson, M. R., Hambly, B., Semsarian, C., Richmond, D. R., Schwartz, K. and Trent, R. J. (1998) Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. J. Med. Genet. 35, 205-210.
8. Moolman-Smook, J., Flashman, E., de Lange, W., Li, Z., Corfield, V., Redwood, C. and Watkins, H. (2002) Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations. Circ. Res. 91, 704-711.